IBM Ventures
VC Fund
San Francisco, United States
IBM Ventures is a VC fund in San Francisco focused on Software and Artificial Intelligence. IBM Ventures is dedicated to driving strategic insights and engagements in growth areas for IBM and its clients. The group was founded in 2001 and is based in San Francisco, California.
- Total investments:
- 36
- Last investment:
- Lead investor:
- 28%
Last updated:
For AI agents: llms.txt
Industries IBM Ventures invests in
Stages IBM Ventures invests in
Countries IBM Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Software 12 (33%)
- Artificial Intelligence 10 (28%)
- Health Care 6 (17%)
- Enterprise Software 6 (17%)
- Information Technology 6 (17%)
Stage
- Series A 6 (17%)
- Series B 5 (14%)
- Series C 5 (14%)
- Funding Round 4 (11%)
- Venture - Series Unknown 4 (11%)
Country
- United States 26 (72%)
- Israel 2 (6%)
- Vietnam 1 (3%)
- United Kingdom 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Angie Grimm
Vice President
|
Vice President | Total investments: 0 | Find email | |
Emily Fontaine
Global Head of Venture Capital and Vice President
|
Global Head of Venture Capital and Vice President | Total investments: 7 | Find email | |
Ben Daniels
Partner
|
Partner | Total investments: 2 | Find email | |
MW Whiteaker
Partner
|
Partner | Total investments: 9 | Find email | |
|
Tom Whiteaker
Co-Founder & Partner
|
Co-Founder & Partner | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
QodeX Quantum
|
QodeX Quantum offers quantum-native AI models and a platform to train and deploy them at scale. | Venture - Series Unknown / Feb 19, 2026 | |
SQK Inc.
|
SQK (Super Quantum Kinetics) is a quantum-AI medical imaging company developing clinically reliable reconstruction and refinement technologies for CT and MRI. The company focuses on physics-constrained imaging pipelines that improve image quality while reducing hallucination risk, with the goal of enabling more trustworthy AI-assisted diagnosticsand scalable deployment in clinical environments.QMEDIC is SQK’s flagship platform for medical image reconstruction and model refinement. Unlike conventional image enhancement tools, QMEDIC uses physics-consistent, data-fidelity-driven processing to suppress artifacts and reduce false image features while preserving diagnostic integrity. The platform is designed to support radiology workflows, improve confidence in low-dose and complex imaging settings, and serve as a reliable foundation for next-generation clinical AI applications. | $500K / Pre-Seed / Jan 19, 2026 | |
Atolio
|
Get internal RAG-based chat with document-level permissions...but ensure your IP stays behind your firewall. | $24M / Series A / Sep 08, 2025 | |
Ox Security
|
Ox Security is the end-to-end software supply chain security platform for DevSecOps. | $60M / Series B / May 07, 2025 | |
|
Ox Security
|
Ox Security is the end-to-end software supply chain security platform for DevSecOps. | $60M / Series B / May 07, 2025 | |
Writer
|
Writer is the AI writing assistant for the world’s smartest brands. We help brand owners and content leaders scale their messaging, communication style, and must-have language, no matter who’s writing. Top brands like Twitter, Intuit, and McKesson have standardized their content creation on Writer. | $200M / Series C / Nov 12, 2024 | |
Reality Defender
|
Reality Defender is the market leader in deepfake detection, protecting enterprises and governments from realtime deepfake and agentic fraud. Sign up for free access at https://www.realitydefender.com/apiAwards: 2025 - Gartner: Recognized as Market Leader in Deepfake Detection 2025 - JPMorgan: Inducted into Hall of Innovation 2025- World Economic Forum: Named Technology Pioneer 2025 - USA DIU + Japan MOD: 1st Place "Global Innovation Challenge" 2024 - RSA Conference: 1st Place “Most Innovative Startup” 2024 - SINET16 Innovator Award 2023 - SXSW 1st Place "Artificial Intelligence, Voice, & Robotics Technologies" | $33M / Series A / Oct 22, 2024 | |
Rohirrim
|
Rohirrim pushes the frontiers of cognitive AI by developing domain-aware content generating technologies.Rohan is a Generative AI platform that applies Document Understanding to ingests your entire data catalog (.ppt, .pdf, .doc, email, slack channel, reports, marketing material, proposal library, white papers, etc.) and weights a LLM making yourdata queryable and domain-aware. Rohan can generate long form, highly technical and unique content that is always sourced to ground truth. | Venture - Series Unknown / Jul 10, 2024 | |
Unstructured Technologies
|
Unstructured Technologies transforms natural language data from raw to machine learning-ready. Its open-source libraries and APIs build custom preprocessing pipelines for labeling, training, or production machine learning pipelines. | $40M / Series B / Mar 14, 2024 | |
Synthetaic
|
Synthetaic is a Delafield, Wisconsin-based company that grows large and high-quality datasets sufficient for machine learning. The company is able to extend AI into industries where data constraints have prevented previous applications of the technology. By focusing specifically on synthetic image data, which is more challenging to produce thancolumnar data, Synthetaic is able to address particularly high-stakes use cases.Through a collaboration with the University of Michigan, Synthetaic is developing a real-time tumor classification AI system that would assist surgeons in identifying what type of brain cancer is present while performing surgery. By combining high-fidelity 3D modeling and novel generative AI with germane, integrated modeling workflows, they deliver an end-to-end pipeline that ensures ultra-high accuracy.Synthetaic was founded in 2019 and is headquartered in Delafield, WI, USA. | $15M / Series B / Feb 06, 2024 | |
| See all 36 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does IBM Ventures invest in?
IBM Ventures invests primarily in Software, Artificial Intelligence and Health Care startups, most often at Series A and Series B stage. Most of the 36 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact IBM Ventures?
Public channels for IBM Ventures include X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at IBM Ventures?
The team at IBM Ventures includes Angie Grimm (Vice President), Emily Fontaine (Global Head of Venture Capital and Vice President) and Ben Daniels (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
